Skip to main content
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1996 Jun;88(6):391–393.

Prolonged amenorrhea associated with total nodal irradiation for Hodgkin's disease.

M Y Halyard 1, J L Cornella 1, G L Grado 1, N R Rizzo 1
PMCID: PMC2608089  PMID: 8691503

Abstract

Pelvic irradiation in the treatment of Hodgkin's disease, including total nodal irradiation, may result in substantial radiation to the ovaries unless oophoropexy and central pelvic shielding is used. Despite such precautions, temporary or permanent amenorrhea may result due to direct or scattered radiation. This article describes a 32-year-old patient who underwent oophoropexy followed by total nodal irradiation for Hodgkin's disease. The patient became amenorrheic for 14 consecutive months. Spontaneous recovery of ovarian function with resumption of menses then occurred and has remained normal to date. The occurrence of prolonged but temporary amenorrhea should be recognized after pelvic radiotherapy for the treatment of Hodgkin's disease.

Full text

PDF
391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker J. W., Morgan R. L., Peckham M. J., Smithers D. W. Preservation of ovarian function in patients requiring radiotherapy for para-aortic and pelvic Hodgkin's disease. Lancet. 1972 Jun 17;1(7764):1307–1308. doi: 10.1016/s0140-6736(72)91035-5. [DOI] [PubMed] [Google Scholar]
  2. Chapman R. M. Effect of cytotoxic therapy on sexuality and gonadal function. Semin Oncol. 1982 Mar;9(1):84–94. [PubMed] [Google Scholar]
  3. Horning S. J., Hoppe R. T., Kaplan H. S., Rosenberg S. A. Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med. 1981 Jun 4;304(23):1377–1382. doi: 10.1056/NEJM198106043042301. [DOI] [PubMed] [Google Scholar]
  4. Hunter M. C., Glees J. P., Gazet J. C. Oophoropexy and ovarian function in the treatment of Hodgkin's disease. Clin Radiol. 1980 Jan;31(1):21–26. doi: 10.1016/s0009-9260(80)80076-6. [DOI] [PubMed] [Google Scholar]
  5. Lushbaugh C. C., Casarett G. W. The effects of gonadal irradiation in clinical radiation therapy: a review. Cancer. 1976 Feb;37(2 Suppl):1111–1125. doi: 10.1002/1097-0142(197602)37:2+<1111::aid-cncr2820370821>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  6. Ray G. R., Trueblood H. W., Enright L. P., Kaplan H. S., Nelsen T. S. Oophoropexy: a means of preserving ovarian function following pelvic megavoltage radiotherapy for Hodgkin's disease. Radiology. 1970 Jul;96(1):175–180. doi: 10.1148/96.1.175. [DOI] [PubMed] [Google Scholar]
  7. Shapiro E., Kinsella T. J., Makuch R. W., Fraass B. A., Glatstein E., Rosenberg S. A., Sherins R. J. Effects of fractionated irradiation of endocrine aspects of testicular function. J Clin Oncol. 1985 Sep;3(9):1232–1239. doi: 10.1200/JCO.1985.3.9.1232. [DOI] [PubMed] [Google Scholar]
  8. Thomas P. R., Winstanly D., Peckham M. J., Austin D. E., Murray M. A., Jacobs H. S. Reproductive and endocrine function in patients with Hodgkin's disease: effects of oophoropexy and irradiation. Br J Cancer. 1976 Feb;33(2):226–231. doi: 10.1038/bjc.1976.29. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES